Compare Stocks

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACAI Safeplus International	$0.00	$0.00	$0.00 ▼ $0.20	$3K	N/A	N/A	N/A
CTTC Calmare Therapeutics		$0.00	$0.00 ▼ $0.02	N/A	N/A	N/A	N/A
RGIN Regenicin	$0.01	$0.00	$0.00 ▼ $0.01	$829K	N/A	9,778 shs	N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACAI Safeplus International	0.00%	0.00%	0.00%	0.00%	-99.31%
CTTC Calmare Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
RGIN Regenicin	0.00%	0.00%	+4,900.00%	+4,900.00%	+233.33%

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACAI Safeplus International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CTTC Calmare Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACAI Safeplus International	N/A	N/A	N/A	N/A
CTTC Calmare Therapeutics	N/A	N/A	N/A	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACAI Safeplus International	N/A	N/A	N/A	N/A	N/A	N/A
CTTC Calmare Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A	($0.04) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACAI Safeplus International	N/A	N/A	∞	N/A	N/A	N/A	N/A	N/A
CTTC Calmare Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RGIN Regenicin	-$640K	N/A	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACAI Safeplus International	N/A	N/A	N/A	N/A	N/A
CTTC Calmare Therapeutics	N/A	N/A	N/A	N/A	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ACAI Safeplus International	N/A
CTTC Calmare Therapeutics	N/A
RGIN Regenicin	0.01%

Insider Ownership

Company	Insider Ownership
ACAI Safeplus International	4.02%
CTTC Calmare Therapeutics	17.50%
RGIN Regenicin	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ACAI Safeplus International	2	25.38 million	24.36 million	Not Optionable
CTTC Calmare Therapeutics	7	N/A	N/A	Not Optionable
RGIN Regenicin	3	165.77 million	N/A	Not Optionable

CTTC, RGIN, and ACAI Headlines

Source	Headline
	Severe cold front hits central, eastern regions; schools forced to delay start of new semester globaltimes.cn - February 21 at 10:59 PM
	Palworld map – all locations, regions, and points of interest pcgamesn.com - February 2 at 10:38 AM
	Alexander boys fend off top challenger in Region 5 ajc.com - January 30 at 7:33 PM
	John Kerry praises Biden for preventing 'uncontrolled war in many regions' foxnews.com - January 20 at 12:10 AM
	Journal of the History of Economic Thought cambridge.org - January 7 at 7:36 AM
	History of computers: A brief timeline livescience.com - December 24 at 7:27 PM
	WATCH: Blue Origin successfully launches rocket in first flight since 2022 crash wlwt.com - December 21 at 3:37 PM
	Blue Origin successfully completes rocket mission more than a year after failed launch nydailynews.com - December 21 at 3:37 PM
	Blue Origin launches New Shepard rocket, aces landing in 1st return to flight since 2022 failure (video) space.com - December 20 at 5:23 PM
	Jeff Bezos’ Blue Origin puts a hold on its first suborbital space launch in 15 months geekwire.com - December 20 at 5:23 PM
	History of Walmart: Timeline and Facts thestreet.com - December 9 at 1:54 PM
	Region police calls – Nov. 28 therepublic.com - December 1 at 12:05 AM
	Air defenses destroy 11 Ukrainian drones over four Russian regions tass.com - November 27 at 10:05 PM
	New Regions Bank coming to Kingsport timesnews.net - November 21 at 6:09 PM
	Florida high school football playoffs: A look at 5 wide open regions in the state theledger.com - November 16 at 7:42 PM
	Florida high school football playoffs: A look at the 5 deepest regions in the state gainesville.com - November 13 at 7:55 AM
	The 12 Regions of China: Past and Present thediplomat.com - October 28 at 7:48 AM
	VHSL power ratings \| Green Run, Maury, Phoebus all lead their regions at midseason pilotonline.com - October 6 at 11:34 PM
	Turtle Shells Record Nuclear History scientificamerican.com - September 14 at 9:47 PM
	Drones target six regions in largest drone attack on Russian soil since start of war in Ukraine nbcbayarea.com - September 7 at 4:29 PM
	Nolensville Little League vs. Smithfield, Rhode Island: Little League World Series score, updates tennessean.com - September 6 at 5:21 AM
	Road Trip of the Regions education.com - September 4 at 4:37 PM
	Heavy rains trigger floods and landslides in India's Himalayan region, leaving at least 48 dead foxnews.com - August 22 at 6:41 PM
	Leveraging Urbanization in South Asia worldbank.org - July 21 at 12:23 AM

Top Headlines

Buy the Dip in Paychex, Inc. for a Pay Check at Retirement
April 2, 2024 11:07 AM
View Buy the Dip in Paychex, Inc. for a Pay Check at Retirement
Oversold and Diverging, Chewy Stock is Ready to Rebound
March 22, 2024 6:10 AM
View Oversold and Diverging, Chewy Stock is Ready to Rebound
WD-40 Company Greases the Wheels of Growth and Profits
April 10, 2024 10:12 AM
View WD-40 Company Greases the Wheels of Growth and Profits
Walt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs
April 1, 2024 9:02 AM
View Walt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs
KB Home’s Stock Price Can Move Higher, Here’s Why
March 21, 2024 11:30 AM
View KB Home’s Stock Price Can Move Higher, Here’s Why

All Headlines

Company Descriptions

Safeplus International

OTCMKTS:ACAI

Safeplus International Holdings Limited develops and markets various technologies for the medical device industries. It is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020. Safeplus International Holdings Limited was founded in 1963 and is based in Pittsford, New York.

Calmare Therapeutics

OTCMKTS:CTTC

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.

Regenicin

OTCMKTS:RGIN

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial